206
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Antioxidative effects of ethyl 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate against amyloid β-induced oxidative cell death via NF-κB, GSK-3β and β-catenin signaling pathways in cultured cortical neurons

, , , , &
Pages 411-421 | Received 01 Sep 2014, Accepted 09 Jan 2015, Published online: 06 Mar 2015

References

  • Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid-β peptide. J Neurochem 1997; 68:255–264.
  • Li MH, Jang JH, Sun B, Surh YJ. Protective effects of oligomers of grape seed polyphenols against beta-amyloid-induced oxidative cell death. Ann NY Acad Sci 2004;1030: 317–329.
  • Adam-Vizi V, Starkov AA. Calcium and mitochondrial reactive oxygen species generation: how to read the facts. J Alzheimers Dis 2010;20:S413–426.
  • Daniels WM, van Rensbury SJ, van Zyl JM, Taljaard JJ. Melatonin prevents β-amyloid-induced lipid peroxidation. J Pineal Res 1998;24:78–82.
  • Yatin SM, Aksenov M, Butterfield DA. The antioxidant vitamin E modulates amyloid b-peptide-induced creatine kinase inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochem Res 1999;24:427–435.
  • Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, et al. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 2001;60:759–767.
  • Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44–84.
  • Moreira PI, Carvalho C, Zhu XW, Smith MA, Perry G. Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology. Biochim Biophys Acta 2010;1802: 2–10.
  • Zhang X, Yin WK, Shia XD, Li Y. Curcumin activates Wnt/β-catenin signaling pathway through inhibiting the activity of GSK-3β in APPswe transfected SY5Y cells. Eur J Pharm Sci 2011;42:540–546.
  • Zhang J, Zhen YF, Pu-Bu-Ci-Ren, Song LG, Kong WN, Shao TM, et al. Salidroside attenuates beta amyloid-induced cognitive deficits via modulating oxidative stress and inflammatory mediators in rat hippocampus. Behav Brain Res 2013; 244:70–81.
  • Kavitha K, Kowshik J, Kishore TK, Baba AB, Nagini S. Astaxanthin inhibits NF-kappaB and Wnt/beta-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim Biophys Acta 2013;1830:4433–4444.
  • Reddy PH. Amyloid beta-induced glycogen synthase kinase 3β phosphorylated VDAC1 in Alzheimer's disease: Implications for synaptic dysfunction and neuronal damage. Biochim Biophys Acta 2013;1832:1913–1921.
  • Martire S, Fuso A, Rotili D, Tempera I, Giordano C, De Zottis I, et al. PARP-1 modulates amyloid beta peptide-induced neuronal damage. PLoS One 2013;8:e72169.
  • Turunc Bayrakdar E, Uyanikgil Y, Kanit L, Koylu E, Yalcin A. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1–42)- induced rat model of Alzheimer's disease. Free Radic Res 2014;48:146–158.
  • Schäfer M, Goodenough S, Moosmann B, Behl C. Inhibition of glycogen synthase kinase 3 beta is involved in the resistance to oxidative stress in neuronal HT22 cells. Brain Res 2004; 1005:84–89.
  • Zou Y, Hong B, Fan L, Zhou L, Liu Y, Wu Q, et al. Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3β/Nrf2 signaling pathway. Free Radic Res 2013; 47:55–63.
  • Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, et al. The binding of 2-(4’-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 2003;23:2086–2092.
  • Leuma Yona R, Mazères S, Faller P, Gras E. Thioflavin derivatives as markers for amyloid-beta fibrils: insights into structural features important for high-affinity binding. Chem Med Chem 2008;3:63–66.
  • Gribkoff VK, Bozik ME. KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine dihydrochloride monohydrate] for the treatment of amyotrophic lateral sclerosis. CNS Neurosci Ther 2008;14:215–226.
  • Anzini M, Chelini A, Mancini A, Cappelli A, Frosini M, Ricci L, et al. Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino (6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases. J Med Chem 2010;53: 734–744.
  • Choi MM, Kim EA, Hahn HG, Nam KD, Yang SJ, Choi SY, et al. Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons. Toxicology 2007;239: 156–166.
  • Kim EA, Hahn HG, Kim TU, Choi SY, Cho SW. Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo. BMB Rep 2010;43:413–418.
  • Huang HC, Chang P, Dai XL, Jiang ZF. Protective effects of curcumin on amyloid-β-induced neuronal oxidative damage. Neurochem Res 2012;37:1584–1597.
  • Feng Z, Zhang JT. Melqatonin reduces amyloid β-induced apoptosis in pheochromocytoma (PC12) cells. J Pineal Res 2004;37:257–266.
  • Hao Q, Lu X, Liu N, Xue X, Li M, Zhang C, et al. Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development. BMB Rep 2013;46:316–321.
  • Kwon DJ, Bae YS, Ju SM, Youn GS, Choi SY, Park J. Salicortin suppresses lipopolysaccharide-stimulated inflammatory responses via blockade of NF-κB and JNK activation in RAW 264.7 macrophages. BMB Rep 2014;47: 318–323.
  • Kim EA, Choi J, Han AR, Choi SY, Hahn HG, Cho SW. Anti-oxidative and anti-inflammatory effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on glutamate- induced neurotoxicity in rat brain. Neurotoxicology 2013;38: 106–114.
  • Ha SC, Han AR, Kim DW, Kim EA, Kim DS, Choi SY, Cho SW. Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain. BMB Rep 2013;46:370–375.
  • Aebi H. Catalase in vitro. Methods Enzymol 1984;105: 121–126.
  • Jho EH, Kang K, Oidovsambuu S, Lee EH, Jung SH, Shin IS, Nho CW. Gymnaster koraiensis and its major components, 3,5-di-O-caffeoylquinic acid and gymnasterkoreayne B, reduce oxidative damage induced by tert-butyl hydroperoxide or acetaminophen in HepG2 cells. BMB Rep 2013;46: 513–518.
  • Rattanajarasroj S, Unchern S. Comparable attenuation of Abeta(25-35)-induced neurotoxicity by quercitrin and 17beta-estradiol in cultured rat hippocampal neurons. Neurochem Res 2010;35:1196–1205.
  • Racker E. Glutathione reductase from bakers’ yeast and beef liver. J Biol Chem 1995;217:855–865.
  • Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357–363.
  • Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA. Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity. J Neurochem 2005;92:749–758.
  • Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of proteins utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248–254.
  • Kim EG, Shin EY. Nuclear Rac1 regulates the bFGF-induced neurite outgrowth in PC12 cells. BMB Rep 2013;46: 617–622.
  • Chen JX, Yan SD. Amyloid-beta-induced mitochondrial dysfunction. J Alzheimers Dis 2007;12:177–184.
  • Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide associated free radical oxidative stress. Free Radic Biol Med 2002;32:1050–1060.
  • Markesbery WR, Lovell MA. DNA oxidation in Alzheimer's disease. Antioxid Redox Signal 2006;8:2039–2045.
  • Spuch C, Ortolano S, Navarro C. New insights in the amyloid-Beta interaction with mitochondria. J Aging Res 2012;2012: 324968.
  • Tayler H, Fraser T, Miners JS, Kehoe PG, Love S. Oxidative balance in Alzheimer's disease: Relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. J Alzheimers Dis 2010;22:1363–1373.
  • Wan L, Nie G, Zhang J, Luo Y, Zhang P, Zhang Z, Zhao B.β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease. Free Radic Biol Med 2011;50: 122–129.
  • Cecchi C, Latorraca S, Sorbi S, Iantomasi T, Favilli F, Vincenzini MT, Liguri G. Glutathione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neurosci Lett 1999;275:152–154.
  • Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 2002; 33:562–571.
  • Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J Neurochem 2003;85:1394–1401.
  • Premkumar DR, Smith MA, Richey PL, Petersen RB, Castellani R, Kutty RK, et al. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 1995;65:1399–1402.
  • Calabrese V, Scapagnini G, Ravagna A, Fariello RG, Giuffrida Stella AM, Abraham NG. Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res 2002;68:65–75.
  • Yoo BC, Seidl R, Cairns N, Lubec G. Heat-shock protein 70 levels in brain of patients with Down syndrome and Alzheimer's disease. J Neural Transm Suppl 1999;57:315–322.
  • Janssen-Heininger YM, Poynter ME, Baeuerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor κB. Free Radic Biol Med 2000;28:1317–1327.
  • Terai K, Matsuo A, McGeer PL. Enhancement of immunoreactivity for NF-kappaB in the hippocampal formation and cerebral cortex of Alzheimer's disease. Brain Res 1996;735:159–168.
  • Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ. ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 2006;281: 20315–20325.
  • Gilmore TD. The Rel/NF-kappaB signal transduction pathway: Introduction. Oncogene 1999;18:6842–6844.
  • Leroy K, Yilmaz Z, Brion JP. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol Appl Neurobiol 2007;33: 43–55.
  • Zhang QG, Wang R, Khan M, Mahesh V, Brann DW. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J Neurosci 2008;28:8430–8441.
  • Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, Inestrosa NC. Signal transduction during amyloid beta peptide neurotoxicity role in Alzheimer disease. Brain Res Brain Res Rev 2004;47:275–289.
  • Ghanevati M, Miller CA. Phospho-beta-catenin accumulation in Alzheimer's disease and in aggresomes attributable to proteasome dysfunction. J Mol Neurosci 2005;25:79–94.
  • Balaramana Y, Limayea AR, Leveyb AI, Srinivasan S. Glycogen synthase kinase 3β and Alzheimer's disease: pathophysiological and therapeutic significance. Cell Mol Life Sci 2006;63:1226–1235.
  • Inestrosa NC, Toledo EM. The role of Wnt signaling in neuronal dysfunction in Alzheimer's disease. Mol Neurodegener 2008;3:9.
  • Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, et al. Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell 2002;2: 323–334.
  • Yi R, Chen B, Zhao J, Zhan X, Zhang L, Liu X, Dong Q. Krüppel-like factor 8 ameliorates Alzheimer's disease by activating β-catenin. J Mol Neurosci 2014;52:231–241.
  • Kuhn PH, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, et al. ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 2010;29:3020–3032.
  • Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 2001;4:233–234.
  • De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998;391:387–390.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.